Drug of Abuse Testing Worldwide Market Size, Revenue, Growth rate & Future Analysis

Drug of abuse testing market forecasted to cross $9.1 billion by 2023. Various samples such as urine, hair and saliva are used for the testing of drug of abuse. The drug of abuse testing market is growing due to technological advancements taking place that increase sensitivity, reduce consumption of time, and facilitate detection of newly developed designer drugs. The increased use of drug of abuse tests for legal and medical purposes has made it imperative to produce results with high confidence levels. As a result, improvement can be observed in various facets such as chemistry, materials, device and equipment.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing/report-sample

Due to increasing consumption of illicit drugs and consecutive initiatives taken by government and other organizations for reducing drug abuse levels are making the organizations aware regarding the need for drug of abuse testing. Other than that, the rise in road accidents and death rates, increased use of drug of abuse testing at organizational level and increased production and trade of illicit drugs worldwide are also the driving the demand for drug of abuse testing products.

As per the findings of the research, consumables held the larger share in the drug of abuse testing market in 2016, since consumable are easily available for use and provide rapid test results when compared to equipment. Rapid test kits are used at a large scale and its consumption is expected to increase at faster rate during the forecast period, since they are easy to use and provide result in a short span of time, as compared to assay kits & reagents.

Explore report at: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing

Globally, the key players in the drug of abuse testing market are acquiring other companies to gain a larger market share in the industry. For instance, in January 2017, Sonic Healthcare Limited acquired Medical Laboratory Bremen, a laboratory in the North-West of Germany. The acquisition was aimed at expanding the former’s presence in Germany and strengthen the company’s commitment to medical leadership in laboratory medicine. The purchase price of $66.8 million (cash and debt free) was funded in Euro from Sonic Healthcare Limited’s existing cash and debt facilities.

Contact: P&S Intelligence Toll-free: +1-888-778-7886 (USA/Canada) International: +1-347-960-6455 Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com